Related Experiment Video
Updated: Aug 26, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Neonatal coxsackie B virus infection-a treatable disease?
Penelope A Bryant1, David Tingay, Peter A Dargaville
1Paediatric Infectious Diseases Unit, Department of Microbiology and Infectious Diseases, Royal Children's Hospital, Parkville, Australia.
Unlabelled:
Ten neonates with coxsackie B viral infection presented over a 3-month period. Clinical features included meningoencephalitis, thrombocytopenia, disseminated intravascular coagulopathy, cardiomyopathy, and hepatitis. Eight infants had multiorgan disease, four with severe myocardial dysfunction, of whom two died. All of the infants with severe disease developed symptoms within 7 days of age. In infants presenting within 10 days of birth, in all cases there were symptoms compatible with maternal infection prior to delivery. Severity was associated with perinatal transmission. Enteroviral polymerase chain reaction of CSF, urine, stool or throat swab was positive in nine of the ten babies. Seven of the infants were treated with a 7-day course of the new anti-picornaviral drug pleconaril (5 mg/kg 3 times daily).
Conclusion:
These cases highlight the importance of not missing coxsackie B viral infection in the differential diagnosis of the septic neonate, especially as there is now a potential treatment.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Bacterial Gastroenteritis
Viral Meningitis
Poliomyelitis
Cryptococcal Meningitis

